Medicare Enrolled
Dr. Moses Kim, MD
Urology Physician · Laguna Hills, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Kim from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Kim?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Kim
Dr. Moses Kim is an urology physician in Laguna Hills, CA, with 18 years of NPI registration. Based on federal Medicare data, Dr. Kim performed 7,652 Medicare services across 3,298 unique beneficiaries.
Between the years covered by Open Payments, Dr. Kim received a total of $128,264 from 37 pharmaceutical and/or device companies across 324 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Kim is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 18 years in practice
▲ Top 14% volume in CA
$128,264 industry payments
Medicare Practice Summary
Medicare Utilization ↗7,652
Medicare services
Top 14% in CA for urology physician
3,298
Unique beneficiaries
$39
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~425 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| BCG treatment for bladder cancer | 2,619 | $2 | $9 |
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
1,601 | $2 | $6 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,010 | $101 | $420 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
527 | $71 | $298 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
473 | $10 | $38 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
247 | $21 | $85 |
| Ceftriaxone antibiotic injection This code represents the administration of ceftriaxone sodium, an antibiotic medication. The charge is calculated for every 250 mg of the drug administered. |
184 | $0 | $1 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
158 | $122 | $542 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
139 | $212 | $831 |
| Bladder instillation of anti-cancer drug A procedure where an anti-cancer medication is introduced directly into the bladder. This method delivers the treatment locally to the bladder tissue. |
105 | $78 | $296 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
93 | $12 | $48 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
74 | $68 | $252 |
| Transrectal ultrasound of the pelvis An ultrasound imaging procedure where a probe is inserted into the rectum to visualize pelvic structures. |
49 | $129 | $709 |
| Ultrasound guidance for needle placement Use of ultrasound imaging to guide the precise placement of a needle during a medical procedure. |
49 | $53 | $196 |
| Bladder irrigation and/or instillation This procedure involves flushing the bladder with fluid to clear it or introducing medication directly into the bladder. |
44 | $69 | $261 |
| Prostate gland biopsy A procedure to remove small samples of tissue from the prostate gland for laboratory examination. |
40 | $205 | $811 |
| Prostate needle biopsy pathology exam Laboratory examination of prostate tissue samples obtained via needle biopsy. The pathologist inspects the tissue both visually and under a microscope to identify any abnormalities. |
40 | $178 | $837 |
| 3D radiographic procedure with computerized image postprocessing A radiographic imaging procedure that creates three-dimensional images using computerized processing of the captured data. |
38 | $70 | $258 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
37 | $149 | $553 |
| Cell examination of specimen, concentration technique A laboratory test that uses a concentration technique to examine cells from a specimen. |
21 | $40 | $158 |
| Simple insertion of temporary bladder tube A procedure to place a temporary tube into the bladder. This allows for the drainage of urine from the bladder. |
20 | $51 | $210 |
| Suture suspension of urethra to control leakage using an endoscope A surgical procedure that uses an endoscope to place sutures that suspend the urethra in order to control urinary leakage. |
20 | $318 | $2,360 |
| Surgical removal of prostate and lymph nodes This procedure involves the surgical removal of the prostate gland and surrounding lymph nodes using an endoscope. |
20 | $1,014 | $3,760 |
| Complete ultrasound of retroperitoneum An ultrasound examination of the structures located behind the abdominal cavity. |
19 | $97 | $377 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
14 | $87 | $365 |
| Transurethral prostate removal with electrocautery This procedure involves removing the prostate gland through the urethra using an endoscope and an electrocautery knife to control bleeding. |
11 | $600 | $2,325 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$128,264
Total received (2018-2024)
Avg $18,323/year across 7 years
Top 4% in CA for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
37
Companies
324
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$117,719 (91.8%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$6,101 (4.8%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$4,444 (3.5%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$39,268
2023
$51,739
2022
$23,632
2021
$8,493
2020
$3,843
2019
$211
2018
$1,079
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
INTUITIVE SURGICAL, INC.
$38,178
ABBVIE INC.
$399
Teleflex LLC
$200
HISTOSONICS,INC.
$148
ACCORD HEALTHCARE, INC.
$145
Photocure Inc
$120
BLUEWIND MEDICAL
$26
Merck Sharp & Dohme LLC
$18
PFIZER INC.
$18
Janssen Biotech, Inc.
$16
Top 3 companies account for 98.7% of 2024 payments
All-time payments by company (2018-2024) ›
Intuitive Surgical, Inc.
$79,865
INTUITIVE SURGICAL, INC.
$38,178
Boston Scientific Corporation
$6,112
ABBVIE INC.
$899
Tolmar, Inc.
$351
Teleflex LLC
$267
Astellas Pharma US Inc
$267
AbbVie, Inc.
$261
Myovant Sciences Inc.
$243
Janssen Biotech, Inc.
$220
AbbVie Inc.
$220
ACCORD HEALTHCARE, INC.
$174
HISTOSONICS,INC.
$148
PFIZER INC.
$124
Photocure Inc
$120
Merck Sharp & Dohme LLC
$85
Dendreon Pharmaceuticals LLC
$78
Allergan, Inc.
$71
UroGen Pharma, Inc.
$65
Axonics, Inc.
$58
Philips Electronics North America Corporation
$51
PALETTE LIFE SCIENCES, INC.
$47
Antares Pharma, Inc.
$46
Avadel Specialty Pharmaceuticals, LLC
$38
Novartis Pharmaceuticals Corporation
$31
Bayer HealthCare Pharmaceuticals Inc.
$29
Medtronic, Inc.
$29
BLUEWIND MEDICAL
$26
Endo Pharmaceuticals Inc.
$23
AstraZeneca Pharmaceuticals LP
$23
Sumitomo Pharma America, Inc.
$22
Palette Life Sciences, Inc.
$19
UROVANT SCIENCES INC
$17
MEDIVATION FIELD SOLUTIONS LLC
$16
BOSTON SCIENTIFIC CORPORATION
$16
Ferring Pharmaceuticals Inc.
$14
Allergan Inc.
$13
Top 3 companies account for 96.8% of all-time payments
Associated products mentioned in payments ›
ALLODERM · AMS 700 · Androgel · Axonics · BOTOX · BOTOX THERAPEUTIC · CAMCEVI · CREON · CYSVIEW · Creon · DA VINCI SP · Da Vinci Surgical System · EDEX · ELIGARD · ERLEADA · FIRMAGON · GEMTESA · INTERSTIM · JATENZO · JELMYTO · KEYTRUDA · LUPRON DEPOT · LUX DX · LYNPARZA · Lasers · Lupron · Lupron Depot · MYRBETRIQ · Myrbetriq · Noctiva · Nubeqa · ORGOVYX · OTREXUP · PLUVICTO · PREMARIN · PROVENGE · REZUM · SpaceOAR System · SpaceOAR VUE System - 10mL · TOVIAZ · UROLIFT · XTANDI · XYOSTED · Xtandi · ZYTIGA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (92%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in urology physician and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 4% for urology physician in CA.
Geographic Context
Urology physicians within 10 mi
140
Per 100K population
4.4
County median income
$113,702
Nearest hospital
MEMORIALCARE SADDLEBACK MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Kim is a clinical cardiology specialist, with above-average Medicare volume (top 14% in CA), with speaking/promotional industry engagement in the top 4% of CA peers, with 18 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Kim experienced with bcg treatment for bladder cancer?
Based on Medicare claims data, Dr. Kim performed 2,619 bcg treatment for bladder cancer services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Kim receive payments from pharmaceutical companies?
Yes. Dr. Kim received a total of $128,264 from 37 companies across 324 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Kim's costs compare to other urology physicians in Laguna Hills?
Dr. Kim's average Medicare payment per service is $39. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Kim) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Urology Physicians in Laguna Hills
Browse urology physicians in Laguna Hills ranked by procedure volume and transparency data.
Highest volume
Top Urology Physicians in CA
Urology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Urology Physicians in CA
Which CA urology physicians receive the most from drug and device companies.
By company
Intuitive Surgical, Inc. Payments to Doctors
See all physicians who received payments from Intuitive Surgical, Inc.
By company
INTUITIVE SURGICAL, INC. Payments to Doctors
See all physicians who received payments from INTUITIVE SURGICAL, INC.
By company
Boston Scientific Corporation Payments to Doctors
See all physicians who received payments from Boston Scientific Corporation.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology